Active ingredientTerfenadineCat. No. P-T061-001CAS 50679-08-8Family · Pharmaceutical analytical standards
Terfenadine
A second-generation H1 antihistamine, synthesised in 1973 and marketed from the 1980s for allergic rhinitis and hives; in the 1990s it was replaced by its active metabolite, fexofenadine. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?It was first made as a potential tranquilliser, but it failed because it does not cross the blood-brain barrier: that is exactly why it became the first antihistamine that does not cause drowsiness.
Go to the active ingredient →Active ingredientTerfenadineCat. No. P-T061-001CAS 50679-08-8
Pharmacopoeial impurityTerfenadine EP Impurity ACat. No. P-T061-003CAS 43076-30-8
Pharmacopoeial impurityTerfenadine EP Impurity BCat. No. P-T061-004CAS 1632048-95-3
Pharmacopoeial impurityTerfenadine EP Impurity CCat. No. P-T061-005CAS 634901-83-0
Pharmacopoeial impurityTerfenadine EP Impurity DCat. No. P-T061-006CAS 93052-68-7
Pharmacopoeial impurityTerfenadine EP Impurity E HydrochlorideCat. No. P-T061-007CAS 2724689-42-1
Pharmacopoeial impurityTerfenadine EP Impurity GCat. No. P-T061-008CAS 104953-06-2
Pharmacopoeial impurityTerfenadine EP Impurity HCat. No. P-T061-009CAS 147158-67-6
Pharmacopoeial impurityTerfenadine EP Impurity JCat. No. P-T061-010CAS 100499-85-2
Impurity(S)-Terfenadine N-OxideCat. No. P-T061-011CAS 2732309-85-0
ImpurityTerfenadine Impurity 1Cat. No. P-T061-012CAS 162096-56-2
ImpurityHydroxy TerfenadineCat. No. P-T061-013CAS 76815-56-0
ImpurityTerfenadine EP Impurity FCat. No. P-T061-014No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceTerfenadine CRSEDQM code T0071000Family TerfenadineImpurityTerfenadine impurity A CRSEDQM code T0080000Family TerfenadineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.